Health Diplomacy Alliance

Tag: global health

  • Health Diplomacy House

    Health Diplomacy House

    On the sidelines of the 79th World Health Assembly, we are pleased to convene the Health Diplomacy House, a full-day multi-event space taking place on Thursday, 21 May 2026, in Geneva. 

    The Health Diplomacy House is an informal, co-creation space where organizations can host sessions, lead discussions, and collaborate on practical solutions to global health challenges. Part of our “Predictable Uncertainty” series of events, the House brings together policymakers, diplomats, academia, civil society, philanthropic organizations, patient groups, and other partners engaged in global health. 

    The objective is to create a space that encourages open dialogue and hands-on collaboration, stepping away from formal settings while addressing complex, evolving global health issues. 

    The House will provide a shared venue for dialogue, reflection, and exchange, featuring:

    While the agenda is open, key areas of some sessions will focus on the following:

    The day will conclude with an informal outdoor* reception, giving participants the chance to continue discussions and connect with colleagues attending the Assembly. 

    If your organization would like to co-create the program by hosting a session, roundtable, or dialogue, please indicate your interest via the short form below by 12 April 2026. We are currently finalizing the agenda with confirmed participants due to limited space. 

    We look forward to welcoming you to the Health Diplomacy House during the 79th WHA.

  • WHO Launches Civil Society Task Force on AMR

    WHO Launches Civil Society Task Force on AMR

     In a significant step to strengthen global action against antimicrobial resistance (AMR), the World Health Organization (WHO) launched the Civil Society Task Force on AMR during World Antimicrobial Awareness Week (WAAW) 2025. The initiative brings together nongovernmental organizations and civil society groups from around the world to coordinate efforts, provide evidence, identify gaps, and promote engagement between governments, communities, and stakeholders.

    The Task Force aims to amplify the voices of affected communities and ensure that civil society organizations can contribute meaningfully to global strategies to combat AMR. Its objectives include fostering collaboration across sectors, supporting capacity building, promoting advocacy, and advancing WHO’s GPW14.

    The Health Diplomacy Alliance (HDA) will be co-sharing the Steering Committee of the Task Force, bringing expertise in health diplomacy and cooperation. HDA’s involvement strengthens efforts to highlight the impact of AMR at global, regional, and national levels, while supporting civil society to engage in advocacy, strengthen regulatory systems, increase access to quality-assured antimicrobials, and integrate the One Health Approach into planning.

    AMR continues to pose a severe global health threat. In 2019, drug-resistant infections were associated with approximately 4.95 million deaths, and by 2021, an estimated 1.14 million deaths were directly attributable to AMR. Without effective measures, healthcare costs could rise by $1 trillion by 2050.

    By including civil society voices alongside technical expertise, the Task Force ensures that AMR responses are locally grounded, equitable, and evidence-based, helping governments and communities implement effective, sustainable solutions.

    HDA’s participation in the Task Force underscores its commitment to promoting long-term, political system-level solutions to address the growing challenge of antimicrobial resistance.